Pacific Biosciences of California (PACB) — Net Asset Quality Index
Pacific Biosciences of California (PACB) has a Net Asset Quality Index of 0.3% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $782.37 Million minus total liabilities of $780.00 Million yields net assets of $2.37 Million. A higher index indicates a stronger, lower-leverage balance sheet. See how many days can Pacific Biosciences of California fund operations to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Pacific Biosciences of California Net Asset Quality Index Over Time (2008–2025)
This chart shows how Pacific Biosciences of California's Net Asset Quality Index has evolved across 18 annual periods from 2008 to 2025. As of March 2026, the index stands at 0.3%, representing net assets of $2.37 Million against total assets of $782.37 Million USD. Explore Pacific Biosciences of California (PACB) cash conversion ratio to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Pacific Biosciences of California (2008–2025)
The table below presents the year-by-year Net Asset Quality Index for Pacific Biosciences of California from 2008 to 2025, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market value of Pacific Biosciences of California.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 0.7% | $5.35 Million | $784.08 Million | $778.73 Million | ▼ -39.5 pp |
| 2024 | 40.2% | $506.59 Million | $1.26 Billion | $753.85 Million | ▲ +0.0 pp |
| 2023 | 40.2% | $701.30 Million | $1.75 Billion | $1.04 Billion | ▲ +8.3 pp |
| 2022 | 31.9% | $562.90 Million | $1.77 Billion | $1.20 Billion | ▼ -7.6 pp |
| 2021 | 39.4% | $790.99 Million | $2.01 Billion | $1.22 Billion | ▼ -41.6 pp |
| 2020 | 81.0% | $335.49 Million | $413.98 Million | $78.49 Million | ▲ +43.9 pp |
| 2019 | 37.1% | $54.92 Million | $147.99 Million | $93.07 Million | ▼ -29.9 pp |
| 2018 | 67.0% | $114.06 Million | $170.28 Million | $56.21 Million | ▲ +7.2 pp |
| 2017 | 59.8% | $86.10 Million | $144.08 Million | $57.98 Million | ▼ -1.6 pp |
| 2016 | 61.4% | $84.67 Million | $137.88 Million | $53.22 Million | ▲ +5.3 pp |
| 2015 | 56.1% | $73.54 Million | $131.11 Million | $57.57 Million | ▲ +12.0 pp |
| 2014 | 44.1% | $54.95 Million | $124.52 Million | $69.57 Million | ▼ -6.7 pp |
| 2013 | 50.8% | $69.18 Million | $136.19 Million | $67.00 Million | ▼ -33.5 pp |
| 2012 | 84.3% | $109.38 Million | $129.68 Million | $20.30 Million | ▼ -3.4 pp |
| 2011 | 87.7% | $191.46 Million | $218.32 Million | $26.85 Million | ▼ -3.8 pp |
| 2010 | 91.5% | $279.87 Million | $305.75 Million | $25.88 Million | ▲ +266.7 pp |
| 2009 | -175.2% | $-177.12 Million | $101.10 Million | $278.22 Million | ▼ -92.6 pp |
| 2008 | -82.6% | $-93.39 Million | $113.11 Million | $206.50 Million | — |